The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development
- PMID: 9543158
- DOI: 10.1210/jcem.83.4.4710
The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development
Abstract
According to the threshold concept, FSH concentrations need to surpass a distinct level to stimulate ovarian follicle growth. The window concept stresses the significance of a limited duration of elevated FSH levels above the threshold for single dominant follicle selection. The aim of this study was to investigate effects on follicle growth of increased FSH levels, differing in duration and magnitude of elevation, during the follicular phase. Twenty-three normo-ovulatory (cycle length, 26-31 days), young (age, 20-31 yr) women volunteered for this study. In all subjects a series of daily transvaginal sonography scans of the ovaries and blood sampling [for FSH and estradiol (E2) determinations] were performed during two consecutive cycles. The first study cycle (control cycle) started 10 days after urinary assessment of the LH surge in the preceding cycle (DayLH) and was concluded on the day of ovulation assessed by transvaginal sonography scans. The second series of daily monitoring (intervention cycle) started 10 days after DayLH in the control cycle. After randomization, subjects received either 375 IU urinary FSH, s.c., as a single injection on Day(LH+14) (group A; n = 11) or 75 IU daily from Day(LH+19) until Day(LH+23) (group B; n = 12). In group A, FSH levels increased on the day after injection to a median concentration of 10.1 IU/L, which was 1.9 times higher (P < 0.01) than levels on matching days during the control cycle. Concentrations returned to basal levels 3 days after injection. In group B, a moderate elevation of FSH concentrations (15% increase; P < 0.05) was observed compared to levels during the control cycle. In group A, E2 concentrations increased (P = 0.03) 1 day after FSH injection and returned to baseline levels within 2 days. In group B, E2 levels started to increase after the first injection of FSH and remained significantly higher (P < 0.01) during the following 5 days compared to those on matching days in the control cycle. Compared to matching days in the control cycle an increased number of follicles 8-10 mm in size was found in group A (P < 0.01) during the period from Day(LH+14) until Day(LH+19), without an increase in follicles 10 mm or larger thereafter. In contrast, in group B, the numbers of both 8- to 10-mm and 10-mm or larger follicles were higher during the period from Day(LH+19) until Day(LH+24) in group B (P = 0.02 and P < 0.01, respectively). Results from the present study suggest that a brief, but distinct, elevation of FSH levels above the threshold in the early follicular phase does not affect dominant follicle development, although the number of small antral follicles did increase. In contrast, a moderate, but continued, elevation of FSH levels during the mid to late follicular phase (effectively preventing decremental FSH concentrations) does interfere with single dominant follicle selection and induces ongoing growth of multiple follicles. These findings substantiate the FSH window concept and support the idea of enhanced sensitivity of more mature follicles for stimulation by FSH. These results may provide the basis for further investigation regarding ovulation induction treatment regimens with reduced complication rates due to overstimulation.
Similar articles
-
Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.Eur J Endocrinol. 2005 Mar;152(3):395-401. doi: 10.1530/eje.1.01871. Eur J Endocrinol. 2005. PMID: 15757856 Clinical Trial.
-
Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.J Clin Endocrinol Metab. 1987 Dec;65(6):1135-40. doi: 10.1210/jcem-65-6-1135. J Clin Endocrinol Metab. 1987. PMID: 2824550
-
Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.J Endocrinol. 1975 Jan;64(1):37-47. doi: 10.1677/joe.0.0640037. J Endocrinol. 1975. PMID: 1167896
-
Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis.Hum Reprod. 1994 Feb;9(2):188-91. doi: 10.1093/oxfordjournals.humrep.a138480. Hum Reprod. 1994. PMID: 8027271 Review.
-
The step-down principle in gonadotrophin treatment and the role of GnRH analogues.Baillieres Clin Obstet Gynaecol. 1993 Jun;7(2):309-30. doi: 10.1016/s0950-3552(05)80133-6. Baillieres Clin Obstet Gynaecol. 1993. PMID: 8358893 Review.
Cited by
-
Mathematical Modeling and Simulation Provides Evidence for New Strategies of Ovarian Stimulation.Front Endocrinol (Lausanne). 2021 Mar 11;12:613048. doi: 10.3389/fendo.2021.613048. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33790856 Free PMC article.
-
Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.J Assist Reprod Genet. 2015 Mar;32(3):429-34. doi: 10.1007/s10815-014-0426-6. Epub 2015 Jan 15. J Assist Reprod Genet. 2015. PMID: 25588963 Free PMC article.
-
A Review on the Use of Letrozole in Female and Male Infertility.Cureus. 2022 Nov 9;14(11):e31291. doi: 10.7759/cureus.31291. eCollection 2022 Nov. Cureus. 2022. PMID: 36514610 Free PMC article. Review.
-
The gonadotropins starting dose calculator, which can be adjusted the target number of oocytes and stimulation duration days to achieve individualized controlled ovarian stimulation in Japanese patients.Reprod Med Biol. 2023 Jan 20;22(1):e12499. doi: 10.1002/rmb2.12499. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 36699956 Free PMC article.
-
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.Reprod Biol Endocrinol. 2011 Jun 21;9:82. doi: 10.1186/1477-7827-9-82. Reprod Biol Endocrinol. 2011. PMID: 21693025 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources